In addition to inhibiting antitumor immunogenicity to enable PD-L1 to bind PD-1 on T lymphocytes, PD-L1 on melanoma cells trans-interacts with PD-1 on melanoma cells, leading to cell proliferation and in vivo tumor growth [72]. Here, PDCD1 is linked to melanoma.